ライフサイエンスコーパス: Newcastle disease

1 mmunization against both avian influenza and Newcastle disease.

2 For poultry, 17.62% (17.37 to 18.04) against Newcastle disease, 16.71% (16.42 to 19.01) against infec

3 ibit the virulence of infectious bronchitis, Newcastle disease, avian influenza, porcine reproductive

4 d widely to protect village chickens against Newcastle disease, due to their decreased dependence on

5 we show that vaccination of chickens against Newcastle disease has a causal impact on children's cons

6 tive vaccination against avian influenza and Newcastle disease in chickens and other poultry.

7 olytic NDV variant that is unlikely to cause Newcastle disease in its avian host, representing an ess

8 mers (SARS-CoV-2) but also to cyclic dimers (Newcastle disease, Lyme disease), trimers (influenza hem

9 Newcastle disease (ND) has a great impact on poultry hea

10 An outbreak of Newcastle disease (ND) in poultry was reported in Belize

11 Newcastle disease (ND) is a deadly avian disease worldwi

12 Newcastle disease (ND) is one of the most important dise

13 es numerous challenges, mainly from frequent Newcastle disease (ND) outbreaks even in vaccinated floc

14 rains of Newcastle disease virus (NDV) cause Newcastle disease (ND), a devastating disease of poultry

15 Newcastle disease (ND), an economically important diseas

16 icken infectious laryngotracheitis (ILT) and Newcastle disease (ND), two of the most economically imp

17 We previously proved that the oncolytic Newcastle disease virus (NDV) activated ferroptosis to k

18 the response of DCs to virus infection with Newcastle disease virus (NDV) after a 24-hour E2 treatme

19 VLP is composed of the NP and M proteins of Newcastle disease virus (NDV) and a chimeric protein con

20 MuRantes mRNA expression is induced by Newcastle disease virus (NDV) and LPS in the RAW 264.7 m

21 The fusion (F) proteins of Newcastle disease virus (NDV) and Nipah virus (NiV) are

22 he level of IFN-beta protein induced by both Newcastle disease virus (NDV) and Sendai virus infection

23 In this study, we have evaluated Newcastle disease virus (NDV) as a vaccine vector for no

24 c and mucosal immune responses by the use of Newcastle disease virus (NDV) as a vaccine vector.

25 linical development of a mesogenic strain of Newcastle disease virus (NDV) as an oncolytic agent for

26 Newcastle disease virus (NDV) belongs to serotype 1 of t

27 Newcastle disease virus (NDV) can cause severe disease i

28 Virulent strains of Newcastle disease virus (NDV) cause Newcastle disease (N

29 Virus-like particles (VLPs) built on the Newcastle disease virus (NDV) core proteins, NP and M, a

30 h virus-like particles (VLPs) containing the Newcastle disease virus (NDV) core proteins, NP and M, a

31 several paramyxoviruses.IMPORTANCE Oncolytic Newcastle disease virus (NDV) could establish persistent

32 Newcastle disease virus (NDV) edits its P gene by insert

33 Newcastle disease virus (NDV) entry into host cells is m

34 Newcastle disease virus (NDV) expressing HIV-1 BaL gp160

35 respiratory tract based on recombinant avian Newcastle disease virus (NDV) expressing the hemagglutin

36 such a stimulus, we generated a recombinant Newcastle disease virus (NDV) expressing the MV hemagglu

37 iotin-labeled peptides with sequences of the Newcastle disease virus (NDV) F protein heptad repeat 2

38 and 289 in the structure and function of the Newcastle disease virus (NDV) F protein was explored by

39 the basis of the coordinates of the related Newcastle disease virus (NDV) F protein, Valine-94, a de

40 ith those of the parainfluenza virus SV5 and Newcastle disease virus (NDV) F proteins, the structures

41 has been demonstrated that the V protein of Newcastle disease virus (NDV) functions as an alpha/beta

42 The effects of Newcastle disease virus (NDV) fusion (F) glycoprotein cl

43 The sequence and structure of the Newcastle disease virus (NDV) fusion (F) protein are con

44 Newcastle disease virus (NDV) fusion (F) protein directs

45 It has been shown that the L289A-mutated Newcastle disease virus (NDV) fusion (F) protein gains t

46 The synthesis of the Newcastle disease virus (NDV) fusion (F) protein in a ce

47 equences in the transmembrane (TM) domain of Newcastle disease virus (NDV) fusion (F) protein in the

48 The role of N-linked glycosylation of the Newcastle disease virus (NDV) fusion (F) protein in vira

49 To explore the association of the Newcastle disease virus (NDV) fusion (F) protein with ch

50 The Newcastle disease virus (NDV) fusion protein (F) mediate

51 y viral fusion proteins, the sequence of the Newcastle disease virus (NDV) fusion protein has several

52 uman parainfluenza virus type 3 (HPIV-3) and Newcastle disease virus (NDV) have been previously evalu

53 Naturally occurring strains of Newcastle disease virus (NDV) have shown oncolytic thera

54 The Newcastle disease virus (NDV) hemagglutinin-neuraminidas

55 onstrate that the F-interactive sites on the Newcastle disease virus (NDV) hemagglutinin-neuraminidas

56 To explore the relationships between Newcastle disease virus (NDV) HN and F protein interacti

57 Newcastle disease virus (NDV) HN and HPIV3 HN respond di

58 The stalk region of the Newcastle disease virus (NDV) HN protein has been implic

59 alysis of the three-dimensional structure of Newcastle disease virus (NDV) HN protein revealed the pr

60 e residues in the functional activity of the Newcastle disease virus (NDV) HN protein.

61 tion, mutations in a conserved domain in the Newcastle disease virus (NDV) HN stalk result in a sharp

62 porated into progeny Sendai virions, whereas Newcastle disease virus (NDV) HN was not.

63 e second receptor-binding site identified in Newcastle disease virus (NDV) HN.

64 morbidity-mortality event involving virulent Newcastle disease virus (NDV) in wild double-crested cor

65 Upon newcastle disease virus (NDV) infection, bone marrow-der

66 We show that, in addition to Newcastle disease virus (NDV) infection, vesicular stoma

67 hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) is a multifunctional prote

68 Newcastle disease virus (NDV) is a negative-sense RNA vi

69 Newcastle disease virus (NDV) is a negative-strand RNA v

70 Newcastle disease virus (NDV) is a threat to the global

71 Newcastle disease virus (NDV) is an attractive candidate

72 hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) is an important determinan

73 Newcastle disease virus (NDV) is an oncolytic virus bein

74 ug-resistant cancers.IMPORTANCEThe oncolytic Newcastle disease virus (NDV) is being developed for use

75 The characteristics of three virulent Newcastle disease virus (NDV) isolates from this outbrea

76 However, VLPs composed of the Newcastle disease virus (NDV) nucleocapsid and membrane

77 The disease is caused by Newcastle disease virus (NDV) or avian paramyxovirus typ

78 A Newcastle disease virus (NDV) outbreak in chickens was r

79 hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) plays a crucial role in th

80 We generated a recombinant Newcastle disease virus (NDV) possessing a two-segmented

81 In the present study, we generated Newcastle disease virus (NDV) recombinants expressing gl

82 In the present study, we generated Newcastle disease virus (NDV) recombinants, based on the

83 tinin-neuraminidase (HN) cytoplasmic tail in Newcastle disease virus (NDV) replication and pathogenic

84 Newcastle disease virus (NDV) replication depends on the

85 The promotion of membrane fusion by Newcastle disease virus (NDV) requires an interaction be

86 Ps) released from avian cells expressing the Newcastle disease virus (NDV) strain AV proteins NP, M,

87 The complete genome sequence of an African Newcastle disease virus (NDV) strain isolated from a chi

88 Newcastle disease virus (NDV) strains are classified as

89 onomic losses, but little is known about the Newcastle disease virus (NDV) strains circulating in Afr

90 Naturally occurring Newcastle disease virus (NDV) strains vary greatly in vi

91 Naturally occurring Newcastle disease virus (NDV) strains vary greatly in vi

92 Eight highly virulent Newcastle disease virus (NDV) strains were isolated from

93 ystallographic structure of an HN dimer from Newcastle disease virus (NDV) suggests that a single sit

94 eloped a COVID-19 vaccine candidate based on Newcastle disease virus (NDV) that can be manufactured a

95 We have generated a recombinant Newcastle disease virus (NDV) that expresses the green f

96 combination of gold nanoparticles (GNPs) and Newcastle disease virus (NDV) to enhance the antitumor e

97 A complete cDNA clone of the Newcastle disease virus (NDV) vaccine strain Hitchner B1

98 Thermostable Newcastle disease virus (NDV) vaccines have been used wi

99 he present study, we generated a recombinant Newcastle disease virus (NDV) vectoring the fusion (F) p

100 Newcastle disease virus (NDV) was isolated from an outbr

101 the membrane cytoskeleton in the assembly of Newcastle disease virus (NDV) were investigated.

102 ression of the fusion glycoprotein of RSV by Newcastle disease virus (NDV) would stimulate a more rob

103 xpression, replication, and pathogenicity of Newcastle disease virus (NDV), a green fluorescent prote

104 Newcastle disease virus (NDV), a member of the family Pa

105 Pteropus vampyrus bat kidney (PVK) cells to Newcastle disease virus (NDV), an avian paramyxovirus kn

106 We evaluated Newcastle disease virus (NDV), an avian paramyxovirus th

107 To address this issue, we evaluated Newcastle disease virus (NDV), an avian paramyxovirus th

108 We previously engineered Newcastle disease virus (NDV), an avian paramyxovirus, a

109 Newcastle disease virus (NDV), an avian paramyxovirus, i

110 Newcastle disease virus (NDV), an avian paramyxovirus, i

111 Newcastle disease virus (NDV), an avian paramyxovirus, i

112 Newcastle disease virus (NDV), an avian paramyxovirus, i

113 Newcastle disease virus (NDV), an avian paramyxovirus, i

114 the F proteins of SV5 (W3A and WR isolates), Newcastle disease virus (NDV), and human parainfluenza v

115 cular stomatitis virus (VSV), Sindbis virus, Newcastle disease virus (NDV), and Sendai virus (SeV), w

116 of the H5 and H7 hemagglutinin subtypes, and Newcastle disease virus (NDV), are important pathogens i

117 Paramyxoviruses, such as Newcastle disease virus (NDV), assemble in and bud from

118 es such as avian metapneumovirus (aMPV), and Newcastle disease virus (NDV), human pathogens such as h

119 Here we find that intratumoral therapy with Newcastle disease virus (NDV), in addition to the activa

120 yxovirus 1 (APMV-1) RNA, also referred to as Newcastle disease virus (NDV), in clinical samples from

121 When infected with Newcastle Disease Virus (NDV), NOD2 expression in DCs wa

122 For Newcastle disease virus (NDV), one bifunctional site (si

123 Virulent and moderately virulent strains of Newcastle disease virus (NDV), representing avian paramy

124 DCs showed a reduced type I IFN response to Newcastle disease virus (NDV), Sendai virus (SeV), and S

125 For many paramyxoviruses, including Newcastle disease virus (NDV), syncytium formation requi

126 ns (UTRs) in replication and pathogenesis of Newcastle disease virus (NDV), we generated recombinant

127 is hypothesis, L929 cells were infected with Newcastle disease virus (NDV), which led to the inductio

128 Cells infected with a Newcastle disease virus (NDV)-expressing VP35 redistribu

129 Newcastle disease virus (NDV)-induced membrane fusion re

130 Newcastle disease virus (NDV)-induced membrane fusion re

131 e effects of lipopolysaccharide (LPS) on the Newcastle disease virus (NDV)-mediated induction of cyto

132 In this study, we show that Newcastle disease virus (NDV)-vectored H7 (NDV-H7) and N

133 We previously showed that a Newcastle disease virus (NDV)-vectored vaccine expressin

134 e of preexisting immunity in humans, such as Newcastle disease virus (NDV).

135 r IRF phosphorylation in cells infected with Newcastle disease virus (NDV).

136 n impacts in situ vaccination with oncolytic Newcastle Disease Virus (NDV).

137 ion with vectored vaccine, using recombinant Newcastle disease virus (rNDV) expressing glycoprotein D

138 A recombinant Newcastle disease virus (rNDV) expressing simian immunod

139 Recombinant Newcastle disease virus (rNDV) stands out as a vaccine v

140 Recombinant Newcastle disease virus (rNDV) strain LaSota expressing

141 A genetically modified, recombinant form of Newcastle disease virus (rNDV) undergoes ionic strength-

142 Here we developed three recombinant Newcastle disease virus (rNDV) vectored vaccines and ass

143 me this obstacle, we generated a recombinant Newcastle disease virus (rNDV)-vectored experimental nor

144 Isolates from the 2002-2003 virulent Newcastle disease virus (v-NDV) outbreak in southern Cal

145 One year after a virulent Newcastle disease virus (vNDV) outbreak in Pakistan, the

146 Newcastle disease virus [NDV (avian paramyxovirus type 1

147 modulate fusion (numbering according to the Newcastle disease virus [NDV] F protein sequence).

148 We found that matrix proteins purified from Newcastle disease virus adsorb on a phospholipid bilayer

149 d RNA viruses that have dsRNA intermediates, Newcastle disease virus and Sendai virus, and a DNA viru

150 Newcastle disease virus and vesicular stomatitis virus (

151 In this study, we found Newcastle disease virus and vesicular stomatitis virus r

152 Newcastle disease virus assembles in plasma membrane dom

153 Here, we present a recombinant Newcastle disease virus expressing a North American line

154 ns for the ability to rescue the growth of a Newcastle disease virus expressing green fluorescent pro

155 mutational analysis of the HR1 domain of the Newcastle disease virus fusion protein, focusing on the

156 This model uses the Newcastle disease virus hemagglutinin-neuraminidase prot

157 on of HN of parainfluenza virus 5 (PIV5) and Newcastle disease virus HN abolishes cell-cell fusion, w

158 Here, we report the structure of the Newcastle disease virus HN ectodomain, revealing dimers

159 embrane fusion, we characterized a series of Newcastle disease virus HN proteins whose surface residu

160 ith functionally active "headless" mumps and Newcastle disease virus HN proteins, provide insights in

161 Mutations of the Newcastle disease virus HN stalk region have been shown

162 e second receptor-binding site identified in Newcastle disease virus HN.

163 ose to the second binding site identified in Newcastle disease virus HN.

164 d receptor binding site of the paramyxovirus Newcastle disease virus in its function and its relation

165 le NF-kappaB activity, both Sendai virus and Newcastle disease virus infection led to robust IFN-beta

166 N expression in response to Sendai virus and Newcastle disease virus infection.

167 ther stimuli, such as lipopolysaccharide and Newcastle disease virus infection.

168 on of interferon beta mRNA 27-fold following Newcastle disease virus infection.

169 As with any other RNA virus, Newcastle disease virus is expected to evolve naturally;

170 opathological characterization of a virulent Newcastle disease virus isolate (NDV-Peru/08) obtained f

171 ed to mimic sites that are found in virulent Newcastle disease virus isolates and to contain 4 or 5 b

172 Eight Newcastle disease virus isolates from Pakistan were sequ

173 Fifteen Newcastle disease virus isolates were recovered only fro

174 AVX/COVID-12 vaccine using a cost-effective Newcastle disease virus LaSota platform to express a sta

175 hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus mediates attachment to sialic ac

176 r ordered assembly and release of infectious Newcastle disease virus particles.

177 or Streptococcus, but not Vibrio cholerae or Newcastle disease virus sialidase.

178 Overexpression of Lgp2 inhibits SV and Newcastle disease virus signaling to IFN-stimulated regu

179 rs by about 2.5-fold, and neuraminidase from Newcastle disease virus typically increased infectivity

180 the growth of a highly IFN-sensitive virus (Newcastle disease virus) in the presence of IFN, suggest

181 ways associated with immune response to NDV (Newcastle disease virus) in the trachea, an essential or

182 aramyxovirus 1 (APMV-1; a group encompassing Newcastle disease virus), which is a highly contagious p

183 ells infected with a heterologous RNA virus (Newcastle disease virus).

184 omography to show that the matrix protein of Newcastle disease virus, a paramyxovirus and relative of

185 mutation is demonstrated in the F protein of Newcastle disease virus, a paramyxovirus of a different

186 nduced by all IL-33-inducing agonists except Newcastle disease virus, a RIG-I agonist that induced ex

187 from non-target viruses such as H6N2, H9N2, Newcastle disease virus, and infectious bronchitis virus

188 efficacy: vaccinia, measles, mumps, viruses, Newcastle disease virus, and reovirus.

189 ense RNA viruses (influenza viruses A and B, Newcastle disease virus, and vesicular stomatitis virus)

190 simplex virus type-1 (HSV-1), Sendai virus, Newcastle disease virus, and vesicular stomatitis virus.

191 PV701, a replication-competent strain of Newcastle disease virus, causes regression of tumor xeno

192 paramyxoviruses measles virus, mumps virus, Newcastle disease virus, human parainfluenza virus 3, an

193 DCs) by negative-strand RNA viruses, such as Newcastle disease virus, leads to the induction of the I

194 ed against CPE resulting from infection with Newcastle disease virus, Sendai virus, canine distemper

195 We report here that for Newcastle disease virus, the HN receptor avidity is incr

196 y this network, we studied DCs infected with Newcastle disease virus, which is able to stimulate inna

197 in primary human dendritic cells infected by Newcastle disease virus, with copy numbers varying from

198 NDV-HXP-S is a recombinant Newcastle disease virus-based vaccine against SARS-CoV-2

199 nd tumor necrosis factor alpha (TNFalpha) in Newcastle disease virus-infected Irf5(-)(/)(-) mice.

200 not type I interferon gene transcription in Newcastle disease virus-infected peritoneal macrophages.

201 Quantitative RT-PCR analysis on Newcastle disease virus-infected primary DCs from 130 in

202 Here we use Newcastle Disease Virus-like particle (NDV-VLP) platform

203 nts similar to the one for cells infected by Newcastle disease virus.

204 ing a control or fusion protein derived from Newcastle disease virus.

205 idase (HN) glycoprotein of the paramyxovirus Newcastle disease virus.

206 onse to HSV-1, but not to Sendai virus or to Newcastle disease virus.

207 d to rescue replication of the IFN-sensitive Newcastle disease virus.

208 Low-virulence Newcastle disease viruses (loNDV) are frequently recover

209 Using reverse genetics, three recombinant Newcastle disease viruses (rNDVs) were engineered, each

210 packaging revealed a majority of infectious Newcastle disease viruses contain one functional genome.

211 Newcastle disease viruses isolated from Hong Kong live b

212 ession after infection with either Sendai or Newcastle disease viruses or after engagement of the Tol

213 W proteins) were expressed from recombinant Newcastle disease viruses, and the responses of infected

214 Using recombinant influenza and Newcastle disease viruses, with or without the NS1 gene